May 2, 2018
The National Cancer Center (NCC) has announced that there were 55 unapproved cancer drugs (65 indications) in Japan which have already been approved overseas as of April 4. Of them, three treatments, including chimeric antigen receptor T cell (CAR-T) therapies,...read more